RecruitingNot ApplicableNCT06285357

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection.

Sponsor

Lo.Li.Pharma s.r.l

Enrollment

100 participants

Start Date

Feb 19, 2024

Study Type

INTERVENTIONAL

Conditions

HPV Infection

Summary

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying EGCG + folic acid + B12 for people with hpv infection. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 25 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.